EconomyInternational Relations
News 3 of 27

US President Trump Announces 200% Tariff on Indian Generic Drugs by 2029

EconomyIntl. RelationsCORE
Target:UPSC GS-IIIMPSCSSC GATeachingBankingPrelims HighMains HighStatic GK Link
22 Jul 2026
~2 min
Source: Indian Express
Key Data:US tariff on Indian pharma: 0%Target tariff: 200%Zero duty window: 2 yearsIndia's pharma export to US: $10.5 billion (FY2025)US share of India's pharma exports: 34.5%Indian generics share in US: 47%
Bodies:PharmexcilIQVIAORFUS Government
Practice MCQs from today's news ▸
What This Article Covers

1.US President Trump announced a phased tariff hike on Indian generic drugs to 200% over 3 years, starting with a 2-year zero-duty period from Aug 1, 2026.

2.India supplies 47% of US generic drug demand, with exports valued at $10.5 billion (34.5% of total pharma exports) in FY2025, making this a critical trade policy shift.

3.Examiner's Angle: Focus on the phased timeline (0% for 2 yrs, 100% for 1 yr, 200% thereafter), the impact on US healthcare costs ($219B savings from Indian generics), and India's strategic response options.

The Big Picture
Prelims · HighMains · High

US President Trump has announced a phased 200% tariff on Indian generic drugs to encourage domestic manufacturing. While the current zero-duty regime continues for two years, the long-term threat to India's $10.5 billion pharma export market is significant. Experts highlight that Indian cost advantages and scale make reshoring difficult for US firms.

Exam Lens

Quick Exam Facts From News

Current US Tariff on Indian Pharma0%
Final Tariff Target200%
Zero Duty Window2 Years (from Aug 1, 2026)
India's Pharma Export to US (FY2025)$10.5 Billion (34.5% of total)
US Generic Drug Supply from India47%
Savings to US Healthcare (2022)$219 Billion

1-Minute Revision

  • ›Current US Tariff on Indian Pharma: 0%
  • ›Final Tariff Target: 200%
  • ›Target this Data: India supplies 47% of US generic drugs, valued at $10.5 billion (34.5% of India's pharma exports) in FY2025.
  • ›Target this Timeline: 0% tariff for 2 years (from Aug 1, 2026), 100% for 1 year, 200% thereafter.
  • ›Target this Body: Pharmaceutical Export Promotion Council of India (Pharmexcil) under Ministry of Commerce and Industry.

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

Q1Static LinkageEasy

Which of the following bodies is responsible for promoting pharmaceutical exports from India, as mentioned in the article?

Q2Statement-basedHard

Consider the following statements:

1. India currently imposes a 10% duty on pharmaceutical products imported from the United States.

2. Indian companies supply 47% of all generic medicines prescribed in the United States.

3. The US tariff on Indian generics will be raised to 200% immediately from August 1, 2026.

Which of the statements given above is/are correct?

Q3Data-centricMedium

According to the article, what was the total value of India's pharmaceutical exports to the United States in FY2025?

Q4Application/ImpactMedium

What is the primary stated objective of the US President's decision to impose a phased 200% tariff on Indian generic drugs?

All 25 MCQs ▸
Read original article from Indian Express
You finished this topic
Practice 3 MCQs from this newsNext Article
Explore Related Topics
EconomyView Topic MCQs →Intl. RelationsView Topic MCQs →
PreviousMeitY Explores Standalone AI Law: Consent Framework for Synthetic Content, Curbs on Agentic AutonomyNext India-U.K. CETA Comes Into Force: Zero-Duty Access for 99% Exports, $100 Billion Trade Target by 2030
Related Current Affairs
Intl. Relations Current Affairs

US-Iran Tensions: Trump Offers Talks, Oil Prices Slide $4/bbl, OPEC+ Approves 188,000 bpd Production Increase

US President Trump announces talks with Iran, calling off planned strikes, leading to a sharp drop in oil prices. Iran insists the Strait of Hormuz will not return to pre-war status, while OPEC+ approves a production increase of 188,000 bpd from September amid ongoing supply disruptions.

Intl. Relations Current Affairs

US Congress Votes to Sanction Top Russian Oil Buyers Including India; Trump Gets Tariff Power

The US Congress has passed the Lindsey O Graham Sanctioning Russia and Iran Act 2026, authorizing the US President to impose up to 100% tariffs on goods from the five largest purchasers of Russian oil, including India. This move intensifies geoeconomic pressure on India, forcing a strategic shift towards 'de-risking' from both the US and China, rather than 'decoupling' from either.

Intl. Relations Current Affairs

US President Trump Backs India-Middle East-Europe Economic Corridor (IMEEC) Against Iranian Threats

US President Donald Trump has announced strong US support for the India-Middle East-Europe Economic Corridor (IMEEC), linking it to the need to shift West Asian energy infrastructure away from Iranian checkpoints after Iran's attacks on commercial shipping. This is a major geostrategic endorsement for a key G20-launched connectivity initiative that directly challenges Iranian influence in the region.

Intl. Relations Current Affairs

Xi's US State Visit: Trump Hosts Musk, Pichai, Altman Amid AI, Rare Earths, Tariff Truce

Chinese President Xi Jinping arrives for his first US state visit in over a decade, with a White House state dinner on September 24 attended by top tech CEOs. Talks will focus on AI, rare-earth supplies, the tariff truce expiring in November, Taiwan and Iran, making this a key geopolitical event for understanding US-China strategic competition.

Intl. Relations Current Affairs

US Imposes 100% Tariff on India Pharma Exports from 2028, Impact on $150 Bn Trade

Trump's unilateral tariff actions on Indian pharmaceutical exports (100% from 2028, rising to 200%) and use of Sections 301, 232, and 338 expose the fragility of ongoing India-US trade negotiations. Despite $150 billion bilateral trade and India's surplus, no signed agreement seems safe. India should prioritize trade diversification towards the UK and EU.

Intl. Relations Current Affairs

US-Iran Talks on Strait of Hormuz Reopening: Oman-Backed Interim Deal Near, India's Energy Security at Stake

US President Trump claims an interim deal with Iran to reopen the Strait of Hormuz is imminent, with Oman and Qatar mediating. Any disruption here directly impacts India's crude oil imports and global energy prices, making this a key IR and energy security topic for exams.

Intl. Relations Current Affairs

Trump Proposes $103,265 H-1B Fee per Cap-Subject Petition; Impacts Indian IT Workers

The Trump administration has proposed a new $103,265 fee on H-1B cap-subject petitions, targeting employers who hire skilled foreign workers. With 71% of approved H-1B petitions going to Indian-born professionals, this proposal could significantly reduce Indian IT workers' access to US jobs, impacting bilateral trade and diaspora interests.

Economy Current Affairs

India-U.S. Trade Pact: Exporters Urge Early Conclusion, Tariff Uncertainty Hits Orders, Trade Surplus Narrows to $33.9 Bn

The Commerce Ministry met exporters to discuss India-U.S. trade performance and market access issues amidst ongoing bilateral trade agreement (BTA) negotiations. Exporters urged early conclusion of the pact to reduce tariff uncertainties, as U.S. buyers have reduced order volumes. The meeting also flagged concerns over U.S. safeguard measures on quartz surface products.

Start Today's Quiz(25 Qs)